{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:55:34Z","timestamp":1785858934706,"version":"3.56.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12,2]]},"DOI":"10.1097\/01.aids.0000194795.20928.2b","type":"journal-article","created":{"date-parts":[[2005,11,10]],"date-time":"2005-11-10T04:11:18Z","timestamp":1131595878000},"page":"2103-2108","source":"Crossref","is-referenced-by-count":18,"title":["Withdrawal of Pneumocystis jirovecii prophylaxis in HIV-infected children under highly active antiretroviral therapy"],"prefix":"10.1097","volume":"19","author":[{"given":"Simon","family":"Urschel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mellado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Giaquinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenda","family":"Verweel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Niehues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Belohradsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Wintergerst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210130","first-page":"1","article-title":"Revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus.","volume":"44","year":"1995","journal-title":"MMWR"},{"key":"R2-6-20210130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02767779","article-title":"Prophylaxis of Pneumocystis carinii pneumonia in HIVinfected children one to five years old: a multicenter surveillance study in paediatric hospitals in Germany","volume":"26","author":"R\u00fcmmelein","year":"1998","journal-title":"Infection"},{"key":"R4-6-20210130","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/00006454-200110000-00006","article-title":"Immune reconstitution in human immunodeficiency virus-infected children receiving highly activated antiretroviral therapy: a cohort study","volume":"20","author":"Johnston","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R5-6-20210130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(98)07204-3","article-title":"Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy","volume":"353","author":"Schneider","year":"1999","journal-title":"Lancet"},{"key":"R6-6-20210130","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199904293401701","article-title":"Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1- infected adults treated with combination antiretroviral therapy","volume":"340","author":"Furrer","year":"1999","journal-title":"N Engl J Med"},{"key":"R7-6-20210130","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(99)03287-0","article-title":"Discontinuation of Pneumocystis carinii pneumonia after start of highly active antiretroviral therapy in HIV-1- infection","volume":"353","author":"Weverling","year":"1999","journal-title":"Lancet"},{"key":"R8-6-20210130","first-page":"201","article-title":"Discontinuation of chemoprophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection","volume":"132","author":"Bienvenido","year":"2000","journal-title":"Ann. Intern Med"},{"key":"R9-6-20210130","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00002030-200103090-00009","article-title":"Discontinuation of primary prophylaxis in HIV-1- infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study","volume":"15","author":"Furrer","year":"2001","journal-title":"AIDS"},{"key":"R10-6-20210130","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1086\/315471","article-title":"Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study","volume":"181","author":"Mussini","year":"2000","journal-title":"J Infect Dis"},{"key":"R11-6-20210130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200101183440301","article-title":"A randomized trial of discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection","volume":"344","author":"Lopez Bernaldo de Quiros","year":"2001","journal-title":"N Engl J Med"},{"key":"R12-6-20210130","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJM200101183440302","article-title":"Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV Infection who have a response to antiretroviral therapy","volume":"344","author":"Ledergerber","year":"2001","journal-title":"N Engl J Med"},{"key":"R13-6-20210130","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1086\/367659","article-title":"Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients: a randomized trial by the CIOP Study Group","volume":"36","author":"Mussini","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R15-6-20210130","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1086\/368413","article-title":"A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team","volume":"187","author":"Aberg","year":"2003","journal-title":"J Infect Dis"},{"key":"R16-6-20210130","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJM200004133421503","article-title":"Discontinuation of prophylaxis for Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS","volume":"342","author":"El-Sadr","year":"2000","journal-title":"N Engl J Med"},{"key":"R18-6-20210130","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1542\/peds.2004-1847","article-title":"The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis","volume":"115","author":"Nachman","year":"2005","journal-title":"Pediatrics"},{"key":"R19-6-20210130","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/00002030-200108170-00024","article-title":"Discontinuation of primary Pneumocystis carinii prophylaxis after reconstitution of CD4 cell counts in HIV-infected children","volume":"15","author":"Urschel","year":"2001","journal-title":"AIDS"},{"key":"R20-6-20210130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00006454-200101000-00008","article-title":"Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy","volume":"20","author":"Dankner","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R21-6-20210130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00006454-200301000-00015","article-title":"Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial","volume":"22","author":"Gibb","year":"2003","journal-title":"Pediatr Infect Dis J"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.aids.0000194795.20928.2b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:58:16Z","timestamp":1785855496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200512020-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,2]]},"references-count":18,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aids.0000194795.20928.2b","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12,2]]}}}